Glycan’s in Vaccine Development

Glycan’s are at the centre of many disorders and diseases igniting the possibility of exploiting them for therapeutic and diagnostic purposes. There are many biochemical pathways and diseases in which glycan’s are intricately involved. Determining the entire capacity and the promise that glycobiology holds, many pharma and biotech companies have already started allocating their R&D budget to it. Presently, with our drug arsenal fast depleting against drug resistant and mutant pathogens, glycobiology hold an untapped source of new candidate drugs.

  • Glycoconjugate vaccines
  • Glycoengineering of immunogens
  • Biomarkers in drug design
  • Biomarkers in drug design
  • Drug interaction in cellular networking
  • Biodefense vaccine mechanism

Related Conference of Glycan’s in Vaccine Development

August 15-16, 2018

16th Asia Pacific Biotechnology Congress

Singapore
August 27-28, 2018

5th International Conference on Glycobiology & Glycoproteomics

Toronto, Ontario, Canada
August 27-28, 2018

3rd International Conference on Molecular Biology & Nucleic Acids

Toronto, Ontario, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018

4th International Conference on Biochemistry & Metabolomics

Los Angeles, California, USA
October 18-19, 2018

10th International Congress on Structural Biology

Helsinki, Finland
October 19-20, 2018

13th International Conference on Structural and Molecular Biology

Ottawa | Ontario | Canada
Nov 19-20, 2018

15th World Congress on Structural Biology

Lisbon, Portugal
February 28-March 01, 2019

5th International Conference on Enzymology and Molecular Biology

Berlin, Germany

22nd Global Congress on Biotechnology

February 28-March 02, 2019 Berlin, Germany

Glycan’s in Vaccine Development Conference Speakers